Revolving door spins freely in Canberra as former senior official taps health network

A former senior official of the Albanese government has ignited fresh scrutiny over the blurred boundary between public office and private influence, after allegedly leveraging insider access to lobby his former department.

Evidence revealed by Sky News shows Nick Martin, formerly Chief of Staff to Federal Health Minister Mark Butler, transitioned directly into a senior policy role at the largest private hospital operator, Ramsay Health Care.

Shortly after leaving the ministerial office, Martin appears to have used meetings with Department of Health officials to advance the private hospital’s position on “reform priorities”, following his prior involvement in private hospital reform policy during his time in government. Ramsay Health Care has also recruited another former staffer to Minister Butler, Billy Moore, who served as his private health adviser and now works as a senior adviser in government relations for the private hospital provider.

The situation has intensified criticism over Australia’s so-called revolving door, with renewed demands for stricter lobbying rules, enhanced transparency over political access, and tighter constraints on the movement of senior government staff into influence-driven roles immediately after leaving office.

Lobbying remains a legitimate feature of democratic systems. Yet the OECD has long acknowledged that lobbying may lead to specific interests being favoured over the public interests.

Australia’s current safeguards remain under pressure. Despite an 18-month cooling off period, former federal ministers can begin lobbying almost immediately after leaving office with minimal enforcement consequences, while only Queensland imposes a two-year restriction aimed at limiting the revolving door effect.

A recent policy brief has outlined emerging international standards for lobbying regulation, assessing Australia’s federal framework against global benchmarks, surveying reforms across jurisdictions, and identifying potential avenues for legislative overhaul.

Dr Yee-Fui Ng from Monash University notes that lobbyists may be engaged on behalf of clients as third-party lobbyists, while the majority operate internally for their employers. She argues that regulating lobbying can help dissuade corrupt behaviour by government official, level the playing field among lobbyists and support merit-based government decision-making.

Institutionally, Australia’s federal model stands out for its limited oversight. Unlike Victoria, Queensland, Tasmania, New South Wales, and the ACT, the Commonwealth lacks an independent regulator responsible for enforcement and compliance. Four out of nine jurisdictions including Queensland, South Australia and New South Wales have dedicated legislation to regulate lobbying activities whereas the Commonwealth has an administrative code of conduct.

Benchmarking further compounds the criticism. According to Transparency International Australia, federal lobbying regulations lag behind those of all states on key transparency measures. On a 10-indicator framework scoring out of 100, the Commonwealth achieved the lowest score of just 17 for lobbying transparency, integrity, and enforcement, with Queensland ranked highest, followed by South Australia.

The regulatory weakness has prompted calls for federal intervention. Independent parliamentarians have increasingly argued the system is overdue for reform. Independent Senator for the ACT David Pocock, Independent Fowler MP Dai Le and Independent Kooyong MP Dr Monique Ryan have all pushed for new legislation to establish a federal lobbying regime capable of matching state-level and international standards.

That backdrop of institutional mistrust is now spilling into broader political sentiment. The latest opinion polling has put One Nation ahead of any third force in Australian politics in the past 80 years. It marks a seismic shift that a minor party is now polling higher than one or even both major parties. We have less than two years to see how it will play out in a Federal election.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.